3–6 g/day divided (to avoid tingling). The effect appears after weeks of loading.
Improves capacity in intense efforts of medium duration.
View the study (meta-analysis) →⏱ 4 min read
Beta-alanine is a non-proteinogenic amino acid (it is not incorporated into proteins like the standard alpha amino acids) whose main biological function is to serve as the rate-limiting substrate for the muscular synthesis of carnosine, the intracellular buffering dipeptide formed by the union of beta-alanine with histidine; this function as a carnosine precursor is the basis of its use as a well-established ergogenic supplement in sports with a lactic anaerobic component (between 60 seconds and 4 minutes of high-intensity effort), where beta-alanine supplementation significantly increases intramuscular buffering capacity and allows performance to be maintained for longer during repeated high-intensity efforts.
Unlike many ergogenic supplements with heterogeneous or controversial data, beta-alanine has a solid scientific basis, with multiple randomized trials and meta-analyses that have confirmed clinically relevant effects on performance in specific disciplines, which places it alongside creatine, caffeine, and nitrates (beetroot) in the small group of ergogenic supplements with top-tier scientific backing recognized by bodies such as the International Olympic Committee and the International Society of Sports Nutrition.
The mechanism of action is clear and well documented: beta-alanine is the limiting amino acid in the muscular synthesis of carnosine (histidine, the other constituent amino acid, is usually available in sufficient amounts), so its exogenous supply allows muscle carnosine concentrations to increase progressively by up to 60-80 percent above baseline levels after 4-12 weeks of sustained supplementation at adequate doses, a physiologically significant change that translates into a better intracellular buffering capacity for the hydrogen ion generated during lactic anaerobic metabolism.
The indication with the best clinical support is performance in repeated high-intensity efforts lasting between 60 seconds and 4 minutes (typically disciplines such as 2,000 m rowing, 200-400 m swimming, track cycling, middle-distance running, MMA, boxing, and team sports with repeated sprints): a meta-analysis published in Amino Acids in 2012 with 15 trials confirmed significant improvements of 2.85 percent in tests lasting 60-240 seconds, a small but competitively relevant magnitude.
In high-volume strength training (many repetitions at moderate-to-high intensities), beta-alanine improves the ability to maintain the number of repetitions and the quality of training, especially in the last sets where the limiting factor is intracellular buffering rather than ATP-PC availability; the effects are more modest in maximal lifts of pure strength (where the limiting factor is neuromuscular, not metabolic).
In older adults with sarcopenia or loss of muscle function, several small studies have shown significant improvements in exercise capacity and in markers of muscle function with supplementation over 12 weeks, an indication consistent with muscle carnosine concentrations that fall with age and that supplementation can partially restore.
The studied and effective dose is 3-6 grams per day divided into 3-4 doses of 0.8-1.6 grams each, with or without food, for at least 4-8 weeks to reach optimal muscle concentrations (loading of muscle carnosine is slow and depends on the total accumulated dose, not the acute dose); sustained-release (SR) products allow larger doses per serving with less paresthesia; the typical cycling is 8-12 weeks of supplementation followed by 4-6 weeks off, although there are data supporting continuous use without the need for a break because of the low rate of degradation of muscle carnosine.
The characteristic and almost unique adverse effect of beta-alanine is paresthesia (a tingling sensation, skin itching, or a feeling of heat in the face, hands, and other exposed areas) that appears 15-30 minutes after acute doses above 800 milligrams and disappears within 30-90 minutes without sequelae; this effect is benign and is due to the activation of specific receptors in cutaneous nerve endings, not to nerve damage or allergy; to minimize paresthesia, divide the daily dose into smaller doses (0.8-1.2 g per dose) or use sustained-release formulations; people with a personal sensitivity to paresthesia may find it unacceptable and stop the treatment; people with abnormal plasma amino acid levels should consult first; in pregnancy and breastfeeding, the specific data as a supplement are limited and it is recommended to avoid it as a precaution; in sports with antidoping controls, beta-alanine is not a prohibited substance and is accepted by all regulatory organizations; the ergogenic effect is modest in magnitude but competitively relevant in specific disciplines, and it is not a universally useful supplement for every type of sport.
Information, not medical advice. Scientific evidence reflects the quality of the studies.